The GNA13 gene plays a crucial role in the development and function of the vascular system, which comprises the body's network of blood vessels. Deficiencies in the GNA13 gene can lead to a range of vascular system defects, potentially causing serious health issues. These defects might manifest as abnormalities in blood vessel formation, maintenance, or function, leading to conditions that could affect blood flow and the delivery of oxygen and nutrients to tissues.
To identify potential GNA13 gene deficiencies, a specific genetic test is available at DNA Labs UAE. This test is designed to analyze the genetic material of individuals to detect mutations in the GNA13 gene that might lead to vascular system defects. By pinpointing such genetic variations, the test can help in the diagnosis of related conditions, enabling healthcare providers to devise appropriate management or treatment plans for affected individuals.
The cost of the GNA13 gene deficiency genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, which requires sophisticated technology and expertise to accurately identify and interpret genetic variations associated with vascular system defects. Individuals who are recommended for this test are often those showing symptoms of vascular abnormalities or those with a family history of related conditions, aiming to provide them with crucial information for managing their health.
The HSD17B10 gene encodes the enzyme 17-beta hydroxysteroid dehydrogenase X, which plays a crucial role in the metabolism of steroids, fatty acids, and amino acids within the mitochondria. Deficiencies in this enzyme can lead to a range of metabolic disorders, including neurological and developmental issues. The genetic test for HSD17B10 deficiency is aimed at identifying mutations in the HSD17B10 gene that are responsible for the enzyme's impaired function. This test is particularly important for early diagnosis and management of the condition, potentially preventing severe outcomes through tailored treatment and interventions.
At DNA Labs UAE, the test for HSD17B10 Gene 17-Beta Hydroxysteroid Dehydrogenase X Deficiency is available for individuals who may be at risk of this genetic disorder. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specific expertise required to accurately identify mutations in the HSD17B10 gene. By choosing to undergo this test at DNA Labs UAE, individuals can expect reliable results backed by state-of-the-art technology and a team of experts specialized in genetic diagnostics. Early detection through this genetic test can be a crucial step in managing the condition effectively, offering individuals and their families a better understanding of the disorder and how to cope with its implications.
The GPR101 gene plays a significant role in growth regulation, and mutations in this gene have been linked to acromegaly, a disorder characterized by excessive growth of bones and tissues. Acromegaly predisposition due to germline GPR101 mutation genetic test is a specialized diagnostic tool designed to identify mutations in the GPR101 gene that may predispose individuals to develop acromegaly. This test is crucial for early detection and management of the condition, potentially preventing severe complications associated with unchecked disease progression.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing a sample of the patient's DNA to look for specific mutations in the GPR101 gene. The process employs cutting-edge technology to ensure accurate and reliable results, providing essential information for patients and their healthcare providers.
The cost of the GPR101 gene acromegaly predisposition genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of early detection and the potential to tailor treatment plans specifically to the genetic makeup of the individual can be invaluable in managing the condition effectively and improving the quality of life for those affected.
The CYP11A1 gene plays a crucial role in the production of steroid hormones in the adrenal gland, including the synthesis of cortisol, aldosterone, and sex steroids. Mutations in the CYP11A1 gene can lead to adrenal insufficiency, a condition characterized by the insufficient production of these vital hormones. This can have profound effects on the body, including electrolyte imbalances, hypotension, and fatigue. Additionally, mutations in this gene can cause 46XY sex reversal, where individuals genetically identified as male (46XY) exhibit female or ambiguous genitalia due to disrupted sex steroid synthesis. This condition can be partial or complete, depending on the extent of the mutation's impact on hormone production.
To diagnose conditions related to the CYP11A1 gene mutation, including congenital adrenal insufficiency and 46XY sex reversal, genetic testing is available at DNA Labs UAE. This specialized test aims to identify mutations in the CYP11A1 gene that might be responsible for these conditions. Understanding the genetic basis of these disorders can aid in the development of personalized treatment plans, including hormone replacement therapy and other interventions to manage symptoms and improve the quality of life for affected individuals.
The cost of the genetic test for the CYP11A1 gene at DNA Labs UAE is 4400 AED. This comprehensive test is a critical tool for individuals presenting symptoms of adrenal insufficiency or ambiguous genitalia, providing them and their healthcare providers with essential information for accurate diagnosis and effective management of these complex conditions.
The TBX19 gene plays a crucial role in the proper functioning of the pituitary gland, particularly in the production of adrenocorticotropic hormone (ACTH), which regulates the adrenal gland's cortisol release. Mutations in the TBX19 gene can lead to a rare condition known as isolated ACTH deficiency, which can result in severe symptoms such as fatigue, muscle weakness, hypoglycemia, and susceptibility to infections due to inadequate cortisol levels.
To diagnose this condition, a genetic test targeting the TBX19 gene can be performed. This test is crucial for confirming the diagnosis of ACTH deficiency caused by TBX19 mutations, guiding treatment decisions, and offering genetic counseling for affected families.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost for the TBX19 Gene Adrenocorticotropic Hormone Deficiency Genetic Test is set at 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and analyzing it for mutations in the TBX19 gene. Results from this test can provide valuable information for managing the condition effectively and offering insight into the genetic basis of the disorder, aiding in the understanding and potentially preventing its transmission to future generations.
The COL4A3 gene plays a critical role in the structure and function of the kidneys, eyes, and ears. Mutations in this gene are associated with Alport Syndrome, a genetic disorder characterized by progressive kidney disease, hearing loss, and eye abnormalities. Alport Syndrome can follow different inheritance patterns, including autosomal recessive, where the individual must inherit two copies of the mutated gene, one from each parent, to be affected.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the COL4A3 gene that are linked to the autosomal recessive form of Alport Syndrome. This test is crucial for early diagnosis, which can significantly impact the management and prognosis of the condition. By analyzing an individual's DNA, the test can confirm a suspected diagnosis, help in the assessment of disease progression, and guide treatment decisions.
The cost of the COL4A3 Gene Alport Syndrome Autosomal Recessive Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive testing service provides valuable information for affected individuals and their families, enabling them to understand their genetic risk and consider appropriate preventive measures or treatments. It's an important resource for those with a family history of Alport Syndrome or healthcare providers looking for a precise diagnosis to tailor patient care effectively.
The COL4A4 gene plays a critical role in the development and function of kidney filtration systems, as well as other organs. Mutations in this gene can lead to Alport Syndrome, a genetic disorder characterized by kidney disease, hearing loss, and eye abnormalities. This condition can follow different inheritance patterns, including autosomal recessive, where both parents must carry one copy of the mutated gene to pass the disorder to their offspring.
At DNA Labs UAE, individuals concerned about their genetic predisposition to Alport Syndrome can undergo a genetic test specifically targeting the COL4A4 gene to determine their carrier status or to confirm a diagnosis. This test is crucial for families with a history of the condition, providing essential information for managing the disease and planning for the future.
The cost of the COL4A4 gene test for Alport Syndrome in an autosomal recessive context is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the COL4A4 gene. Results from this test can help guide clinical decisions, including monitoring for kidney and hearing problems, and can inform patients and their families about the risk of passing the condition to future generations.
The COL4A5 Gene Alport Syndrome X-Linked Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the COL4A5 gene, which are responsible for the development of Alport Syndrome. This genetic condition is predominantly inherited in an X-linked manner, affecting mainly males, though females can be carriers and may exhibit milder symptoms. Alport Syndrome is characterized by kidney disease, hearing loss, and eye abnormalities, resulting from defects in the type IV collagen, a crucial component for tissue structures in these organs.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the COL4A5 gene. This precise genetic testing is crucial for early diagnosis, allowing for timely management and treatment of the condition, potentially slowing its progression and improving the quality of life for those affected.
The cost of the COL4A5 Gene Alport Syndrome X-Linked Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the specific mutations within the gene, providing essential information for affected individuals and their families regarding the inheritance pattern, prognosis, and available treatment options.
The AR Gene Androgen Insensitivity Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the Androgen Receptor (AR) gene. These mutations are known to cause Androgen Insensitivity Syndrome (AIS), a condition that affects sexual development before birth and during puberty. Individuals with AIS may have male genetic makeup (XY chromosomes) but their bodies can partially or completely be insensitive to androgens, the hormones that typically influence male traits and reproductive development.
The test is particularly valuable for families with a history of AIS, or in cases where a child's sexual development seems atypical. Early diagnosis can assist in managing the condition, helping in making informed decisions about the care and treatment options available.
DNA Labs UAE offers this test for a cost of 4400 AED. The process involves a simple collection of a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in their state-of-the-art laboratory facilities. The test seeks to identify any anomalies in the AR gene that might indicate the presence of Androgen Insensitivity Syndrome, providing crucial information for individuals and families dealing with the complexities of the condition.
The "AR Gene Androgen Insensitivity Partial with or without Breast Cancer Genetic Test" offered by DNA Labs UAE is a sophisticated diagnostic tool designed to detect variations in the AR (Androgen Receptor) gene that are associated with Partial Androgen Insensitivity Syndrome (PAIS) and potential links to breast cancer. This test is particularly significant for individuals experiencing symptoms of PAIS, such as ambiguous genitalia, underdeveloped male genitalia, or infertility in individuals assigned male at birth, as well as those with a family history of breast cancer who may carry genetic variations linked to increased risk.
The cost of the test is 4400 AED, reflecting the comprehensive analysis and the detailed report provided. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and adherence to international standards, this test involves a non-invasive procedure, usually requiring only a blood sample from the patient. The results not only offer insights into the genetic underpinnings of the patient's condition but also guide personalized treatment and management plans, including preventive measures for associated risks such as breast cancer. This test is a critical step towards understanding and managing genetic conditions, ensuring patients and their families can make informed decisions about their health.
